Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$5,858,682
+$771,591 QoQ
Shares Held
23,282
-0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#1,217
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Claro Advisors Inc. holds $23,719,798 across 11 Drug Manufacturers - General names. ABBV ranks #1 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
23,282 | $5,858,682 | |
| 2 | JNJ |
Johnson & Johnson
|
22,661 | $5,755,214 | |
| 3 | LLY |
ELI LILLY & Co
|
3,896 | $4,672,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,805 | $1,516,942 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,313 | $1,400,915 | |
| 6 | AMGN |
Amgen Inc
|
3,385 | $1,225,776 | |
| 7 | PFE |
Pfizer Inc
|
47,000 | $1,131,760 | |
| 8 | NVO |
Novo Nordisk A S
|
21,612 | $1,036,079 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,858,682 | 23,282 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $5,087,091 | 23,390 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $4,919,161 | 21,529 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,922,540 | 21,260 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,907,672 | 21,052 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $4,739,342 | 22,620 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $4,104,870 | 23,100 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $4,883,482 | 24,729 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,995,729 | 23,296 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $4,363,480 | 23,962 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $3,657,137 | 23,599 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $3,786,273 | 25,401 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $3,208,999 | 23,818 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,623,389 | 16,461 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $2,703,735 | 16,730 | Shares | Sole | 2023-03-13 | |
| 2022-09-30 | $2,063,881 | 15,378 | Shares | Sole | 2022-11-18 | |
| 2022-06-30 | $2,355,294 | 15,378 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,902,522 | 11,736 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,589,054 | 11,736 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,157,984 | 10,735 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,058,703 | 9,399 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $997,030 | 9,213 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $879,594 | 8,209 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $777,624 | 8,878 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $891,867 | 9,084 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $569,748 | 7,478 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||